| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.36B | +2.9% |
| Cost of Revenue | $675.4M | -1.4% |
| Gross Profit | $680.2M | +7.4% |
| R&D Expense | $1.0M | -41.2% |
| SG&A Expense | $524.5M | +43.0% |
| Operating Income | $155.7M | -41.5% |
| Pre-tax Income | $195.1M | -33.1% |
| Income Tax | $50.0M | -23.1% |
| Net Income | $145.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $890.2M | +17.8% |
| Accounts Receivable | $270.3M | +47.2% |
| Inventory | $131.2M | -42.8% |
| Current Assets | $1.32B | +9.9% |
| Total Assets | $1.77B | +15.0% |
| Current Liabilities | $365.5M | +32.1% |
| Total Liabilities | $542.5M | +21.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $262.9M | +86.2% |
| Capital Expenditures | $23.4M | +34.2% |
| Investing Cash Flow | -$101.7M | -616.4% |
| Financing Cash Flow | -$26.0M | -3.0% |
| Free Cash Flow | $239.5M | +93.5% |
| -36.0% |
| EPS (Basic) | $0.46 | -41.8% |
| EPS (Diluted) | $0.45 | -41.6% |
| Stockholders' Equity |
| $399.9M |
| +51.5% |